I feel I’m WAY overdue with this meme. I mean, someone had to do it. Context: Perkins GD, Ji C, Deakin CD, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. N Engl J Med. 2018;379(8):711-721. doi:10.1056/NEJMoa1806842 https://t.co/e2zg0SNQSV
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2018 – Aug 2025Where it's discussed
-
X / Twitter123 posts
-
Facebook86 posts
-
News42 articles
-
Blogs30 articles
-
Bluesky6 posts
-
Reddit5 posts
-
YouTube4 videos
AI synopsis
What people are saying
The discussions highlight the nuanced effects of epinephrine, with posts mentioning increased ROSC and 30-day survival but also worse neurological outcomes, using words like 'challenged dogma' and 'controversial,' which reflect both engagement and concern about the implications for practice and patient quality of life.
Most discussions acknowledge that while epinephrine increases short-term survival, it does not improve long-term neurological outcomes, showing cautious agreement.
There is a high level of interest in the trial's results and implications, with many engaging with detailed analyses and questioning guidelines.
Discussions reference clinical trials, outcomes, and ethical considerations, indicating deep engagement with the study's findings.
The debate around the balance of survival and neurological impairment suggests moderate impact on current medical practices, though some argue for reevaluation of standard protocols.
Abstract in brief
- The trial found that administering epinephrine during out-of-hospital cardiac arrests increased the overall 30-day survival rate compared to a placebo, but there was no significant difference in the number of patients with good neurological outcomes after recovery.
- More patients in the epinephrine group survived to hospital discharge but experienced more severe neurological impairments, suggesting that while epinephrine may help more people survive, it might also increase the risk of significant brain injury.
- The study highlights the need to weigh the benefits of increased survival against the potential for worse neurological recovery when considering epinephrine as a treatment during cardiac emergencies outside the hospital.
Top posts
Most liked on X and BlueskyWe pursued this work in the context of the PARAMEDIC-2 trial, published in @NEJM in 2018. https://t.co/GKjt2CpV1v PARAMEDIC-2 found that epinephrine improved 30-day survival, but also found no improvement in survival with good functional outcomes (a secondary outcome). https://t.co/R8VSxZz4TX
6/ What about neurologic outcomes? Rates of survival with favorable neurologic outcomes were no different: ➤2.2% epinephrine ➤1.9% placebo But, rates of severe neurologic impairment were higher in the epinephrine arm: ➤31% epinephrine ➤18% placebo https://t.co/HNRMb2TYuo https://t.co/3X6TFDVe9S
Let's kick off our fave pre-hospital trials for this #EMSWeek2020: First up is #PARAMEDIC2! Well designed and executed to answer a challenging question - does epi improve outcomes in #OHCA? Still generating discussion 2 years later https://t.co/Dh9Cp8UliK
PARAMEDIC-2: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - Gavin Perkins https://t.co/MB2YeORR7g https://t.co/GoDthQlfym
院外心停止に対して、エピネフリン vs プラセボを比較したPARAMEDIC2はこちら。 https://t.co/0lFlouqrci
All mentions
Advanced Pediatric Cardiopulmonary Resuscitation and Epinephrine Use
This video discusses advanced pediatric life support techniques, team coordination, ethical considerations, and a comprehensive flowchart for emergency response, emphasizing the importance of quality care during…
Epinephrine in Cardiac Arrest: Survival Benefits and Neurological Outcomes
Epinephrine during out-of-hospital cardiac arrests showed increased 30-day survival but no significant improvement in neurological outcomes, raising questions about its overall benefit in emergency treatment.
Coronary Calcium Score and its Role in Cardiovascular Risk Assessment
This video discusses coronary artery calcium (CAC) as a specific indicator of coronary atherosclerosis. It explores how CAC scoring guides preventive treatments, predicts cardiovascular events, influences clinical…
Optimizing Epinephrine Use in Out-of-Hospital Cardiac Arrests
This episode discusses the impact of epinephrine administration during out-of-hospital cardiac arrests, highlighting increased 30-day survival but also the potential for severe neurological impairments, emphasizing the…
d'autre que ramener plus de vivants à l'hôpital, mais n'améliorait pas le pronostic à long terme dans PARAMEDIC 2 évoqué plus haut...vous avez un peu plus de "vivants". Mais ils sont dans de très piteux états neurologiques...Soit parce que vous avez fait repartir pubmed.ncbi.nlm.nih.gov/30021076/
@KateShemirani 3. PARAMEDIC-2 results can be found here. The study write up does not include the quote “Patients could only be included if organ donation was possible post-resuscitation.” Please can you explain where that comes from (the link provided does not work) https://t.co/E4yPqtvph2
Read this carefully @BBCPanorama https://t.co/AijWHutaqZ https://t.co/TUWjANBJpq
Good God @wesstreeting how is this possible- it’s beyond monstrous https://t.co/AijWHutaqZ https://t.co/TUWjANBJpq
@UnityNewsNet @KateShemirani Probably important for Mr McCrae (and anyone else who is interested) to actually read the results from the Paramedics 2 trial rather than relying on others’ interpretations. Here it is https://t.co/inVi2pyHU7
@LaceDeb @TaniLinton @KateShemirani That it significantly increases survival in out of hospital cardiac arrest from the paramedic 2 trial? https://t.co/inVi2pzfJF
@Nullen80 of organ transplantation in this trial. https://t.co/6t5b9JaQbp
@aunty_vax @rdt55555 @angelalake @GabrielCyShemi Paramedic 2 shows that your chances of surviving 30d were statistically less if you didn’t receive adrenaline whilst in cardiac arrest. You can read the trial results here https://t.co/inVi2pyHU7
...is full of narcissists. I am not saying that Shimirani is another one but I wouldn't be surprised to learn that she was. As for Shimirani's allegations. The Paramedic 2 and 3 trials out of Warwick did happen and are underway respectively. https://t.co/6aAYmpJ7ud
Yes but... The survival rate are the same as when I was a student... pubmed.ncbi.nlm.nih.gov/30021076/
@structureltp @MichaelMindrum @BudoffMd @realDaveFeldman @realCSF @the_lundquist "Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19" "Surgisphere COVID-19 Studies" "A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest" (Note: criticized, not retracted, for outcome reporting issues)
@Rcub1721 https://t.co/zKolaqDs6U)%20(Table%203).
@KateShemirani 3/4 They also note in their discussion that public consultation “identified survival with a favorable neurologic outcome to be a higher priority than survival alone.” See DOI: 10.1056/NEJMoa1806842
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest | New England Journal of Medicine https://t.co/wRBp3zHsq0
@fortybam @ross_prager @IM_Crit_ @NephroP @EM_RESUS @PulmCrit @emcrit @katiewiskar @nickmmark Severe neurologic impairment (mRS 4 or 5) was more common among survivors in the epinephrine groups compared to the placebo group (31.0% vs. 17.8%). https://t.co/CoC7cb1HbG @NEJM
Why did we do PARAMEDIC-3? Our starting point- drugs in cardiac arrest do work. In PARAMEDIC-2, adrenaline had a huge effect on ROSC- it ⬆️increases the odds of achieving ROSC by 3⃣. The effect on 30-day survival is smaller but still important. https://t.co/mvc3hnjc0m (2/n)
心停止蘇生後の低酸素脳症6
@lE9BrvyUwLLVZIE https://t.co/6zBiqZAgDB そうですね、そんな感じです
PARAMEDIC-2: Adrenaline given during cardiac arrest does not increase survival with favourable neurological outcome and produces more survivors with severe neurologic impairment https://t.co/F47gQCxiT4 https://t.co/k8ryWKJMcD
@CatherineCounts @slcfire I guess it’s congruent with Paramedic 2, though with better survival https://t.co/ARNZon1z8i
RT @yotsumex: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest | NEJM https://t.co/UMTPA0na4b 現場レベルではアドレナリンの効果を肌感覚として感じ…
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest | NEJM https://t.co/UMTPA0na4b 現場レベルではアドレナリンの効果を肌感覚として感じることができないのは、30日生存を達成するための治療必要数ーNNT(number needed to treat)ーが112だからです。
@davidcarr333 @sadiyeayhan Totally agree! Paramedic2 (2018) told us already, but „for some reason“ didn’t make it into the guidelines
@CARE_1975 @NYCEMSwatch And probably not epinephrine. Sure you get ROSC but the end outcome may be worse. As you note, BLS is the key. https://t.co/am6YPlzqjh
OHCA/IHCA/Peri-arrest/low flow states In need of some RCT diagnostic/managerial refinement. Will be challenging. Carotid Pulse https://t.co/YY5xQzBDah Paramedic2 https://t.co/LAMugWo4a4 All or nothing still
#TrialOfTheDay for July 18th is the PARAMEDIC2 trial, published ahead of print on this date in 2018 in @NEJM Demonstrating efficacy for epinephrine in out-of-hospital cardiac arrest Open-access article link: https://t.co/yU8TpiGrSz #pharmicu #pharmem #ems #emrx #twitterx https://t.co/lUpWqFiTw3
@tamishtah Paramedic 2(2018) study of adrenaline vs. placebo: but lets look at it for times. 999 arrival 6.6 mins, 30-day survival 3.2% (intervention) vs. 2.4% (control) https://t.co/1gelnotpFz
@wolfhautz @hellfridge1 Hierzu dies
@Old_stoneface31 PARAMEDIC2 - 10.1056/NEJMoa1806842 EPIC - 10.1001%2Fjamasurg.2019.1152 PART - 10.1001%2Fjama.2018.7044 AIRWAYS 2 - 10.1001/jama.2018.11597 CAAM - 10.1001/jama.2018.0156 DSED - 10.1056/NEJMoa2207304 ALPS - 10.1056/NEJMoa1514204 CRASH 2 - 10.3310/hta17100
We pursued this work in the context of the PARAMEDIC-2 trial, published in @NEJM in 2018. https://t.co/GKjt2CpV1v PARAMEDIC-2 found that epinephrine improved 30-day survival, but also found no improvement in survival with good functional outcomes (a secondary outcome). https://t.co/R8VSxZz4TX
@____Dopamine___ Je conçois que ce soit variable car j ai fait un peu de samu. Néanmoins c est bien plus la pression des habitudes qu un vrai rationnel hormis le patient incarcéré comme dit avant. Je vous donne un exemple illustratif https://t.co/HF8UNSc1AM Les certitudes sont discutables
RT @teddyhla: @ESICM PARAMEDIC 2 - big study 8007 pts, adrenaline 4000, placebo 3999 - a lot of discussion post trial - need a nuanced int…
RT @teddyhla: @ESICM PARAMEDIC 2 - big study 8007 pts, adrenaline 4000, placebo 3999 - a lot of discussion post trial - need a nuanced int…
@ESICM PARAMEDIC 2 - big study 8007 pts, adrenaline 4000, placebo 3999 - a lot of discussion post trial - need a nuanced interpretation. - 19 "more good" survivors and 5 "more bad" survivors in adrenaline arm. https://t.co/1gelnotpFz
The paramedic2 trial being described by Gavin Perkins #SOA22 https://t.co/jZBlaohy4Z
RT @MUE_14: .@rvarel Adrenalina en PCR: - mejora ROSC - no mejora sobrevida neurologicamente intacto ¿Será momento de sacarla de los algo…
RT @MUE_14: .@rvarel Adrenalina en PCR: - mejora ROSC - no mejora sobrevida neurologicamente intacto ¿Será momento de sacarla de los algo…
RT @MUE_14: .@rvarel Adrenalina en PCR: - mejora ROSC - no mejora sobrevida neurologicamente intacto ¿Será momento de sacarla de los algo…
RT @MUE_14: .@rvarel Adrenalina en PCR: - mejora ROSC - no mejora sobrevida neurologicamente intacto ¿Será momento de sacarla de los algo…
RT @MUE_14: .@rvarel Adrenalina en PCR: - mejora ROSC - no mejora sobrevida neurologicamente intacto ¿Será momento de sacarla de los algo…
RT @MUE_14: .@rvarel Adrenalina en PCR: - mejora ROSC - no mejora sobrevida neurologicamente intacto ¿Será momento de sacarla de los algo…
.@rvarel Adrenalina en PCR: - mejora ROSC - no mejora sobrevida neurologicamente intacto ¿Será momento de sacarla de los algoritmos?
RT @tony_breu: 4/ This was followed by a 2018 randomized, placebo-controlled trial. It included 8014 patients with out-of-hospital cardiac…
placebo https://pubmed.ncbi.nlm.nih.gov/30021076/
6/ What about neurologic outcomes? Rates of survival with favorable neurologic outcomes were no different: ➤2.2% epinephrine ➤1.9% placebo But, rates of severe neurologic impairment were higher in the epinephrine arm: ➤31% epinephrine ➤18% placebo https://t.co/HNRMb2TYuo https://t.co/3X6TFDVe9S
5/ The rates of return of spontaneous circulation (ROSC) were significantly higher in the epinephrine arm: ➤36% epinephrine ➤12% placebo 30-day survival was also higher in the epinephrine arm: ➤3.2% epinephrine ➤2.4% placebo https://t.co/HNRMb2TYuo https://t.co/Ak9w4dAuxj
5/ The rates of return of spontaneous circulation (ROSC) were significantly higher in the epinephrine arm: ➤36% epinephrine ➤12% placebo 30-day survival was also higher in the epinephrine arm: ➤3.2% epinephrine ➤2.4% placebo https://pubmed.ncbi.nlm.nih.gov/30021076/
4/ This was followed by a 2018 randomized, placebo-controlled trial. It included 8014 patients with out-of-hospital cardiac arrest. Patients received either epinephrine or a saline placebo. https://t.co/HNRMb2TYuo https://t.co/B3T5INsSKk
4/ This was followed by a 2018 randomized, placebo-controlled trial. It included 8014 patients with out-of-hospital cardiac arrest. Patients received either epinephrine or a saline placebo. https://pubmed.ncbi.nlm.nih.gov/30021076/
RT @DrJeffJarvis: I feel I’m WAY overdue with this meme. I mean, someone had to do it. Context: Perkins GD, Ji C, Deakin CD, et al. A Ran…
RT @DrJeffJarvis: I feel I’m WAY overdue with this meme. I mean, someone had to do it. Context: Perkins GD, Ji C, Deakin CD, et al. A Ran…
RT @DrJeffJarvis: I feel I’m WAY overdue with this meme. I mean, someone had to do it. Context: Perkins GD, Ji C, Deakin CD, et al. A Ran…
RT @DrJeffJarvis: I feel I’m WAY overdue with this meme. I mean, someone had to do it. Context: Perkins GD, Ji C, Deakin CD, et al. A Ran…
RT @DrJeffJarvis: I feel I’m WAY overdue with this meme. I mean, someone had to do it. Context: Perkins GD, Ji C, Deakin CD, et al. A Ran…
I feel I’m WAY overdue with this meme. I mean, someone had to do it. Context: Perkins GD, Ji C, Deakin CD, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. N Engl J Med. 2018;379(8):711-721. doi:10.1056/NEJMoa1806842 https://t.co/e2zg0SNQSV
RT @AnesthCritCare: #Epinephrine in Out-of-Hospital Cardiac Arrest #PARAMEDIC2 trial: good to restart the heart but bad for the brain? Epi…
RT @SayreMR: Prehospital epinephrine at a dose of 1 mg every 3-5 minutes does NOT increase neurologically intact survival from out-of-hospi…
RT @AmirLotfi9: @yeh_james3 @drthangtm https://t.co/ADIiGkOcQN
RT @AmirLotfi9: @yeh_james3 @drthangtm https://t.co/ADIiGkOcQN
@yeh_james3 @drthangtm https://t.co/ADIiGkOcQN
RT @ACParamedicine: The Paramedic 2 Trial - A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - is one of the RTCs which…
RT @ACParamedicine: The Paramedic 2 Trial - A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - is one of the RTCs which…
The Paramedic 2 Trial - A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - is one of the RTCs which our #TalkingResearch guests Helen Pocock & Tom Quinn have been involved with. Interested in learning more? Join us online on November 10 https://t.co/oUTH37sAvZ https://t.co/xiymXdSKez
@4mmk36 @emlitofnote @First10EM Similar arguments were made about lack of equipoise & near impossibility to conduct an RCT on epinephrine for OHCA. Epinephrine is part of ACLS algorithm and supported by many guidelines including the AHA. Yet the study was done. https://t.co/CIjgc044Ri
@macwalterMD @CritCareReviews There's a great review of evidence of epi in arrest, and then the PARAMEDIC-2 trialp published after the review, also showing increased ROSC but worse neurologic outcomes. https://t.co/JUWXDc5at8 https://t.co/qEAQNSGnOF
@R3cklinghausen https://t.co/qNHH4cTROZ Oui. Mais de l’outcome clinique qui ne rend pas forcément service au patient et à sa vie future.
RT @DavidZodda: The number needed to treat (NNT) to prevent one death after cardiac arrest. Courtesy of the PARAMEDIC2 Trial. - Early Defi…
@DrAnkushSinghal You are absolutely right. I was shocked too. I don’t know if the relatives of the dead people who were given placebo were ever told. https://t.co/b4TggI8vsn
@kRYNu54oWVZUH6c これを読んでどう思うかです A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/NLPCZiCtLM
5/ #paramedic2 trial (2018)
Today is a good reminder that all other interventions are secondary to high-quality CPR and early defibrillation in OHCA (from: https://t.co/mCecC2WBZx) https://t.co/UJkvBxBVxM
@DIntubator Bon on fait les malins mais l'adrénaline fait pas mieux comme outcome à un mois d'un ACR contre un placebo. https://t.co/eXQj6XKU3c
RT @DrJeffJarvis: I’m thinking about PARAMEDIC2 again tonight. 0.8% improved 30 day survival w/o improved neuro survival and 13% more neu…
RT @DrJeffJarvis: I’m thinking about PARAMEDIC2 again tonight. 0.8% improved 30 day survival w/o improved neuro survival and 13% more neu…
I’m thinking about PARAMEDIC2 again tonight. 0.8% improved 30 day survival w/o improved neuro survival and 13% more neuro devastation among survivors. NNT 112 for survival vs 5 for early defib. 0% probability of at least 2% neuro survival. 1/2 https://t.co/noBas79qNW
@BrianKingNeo @DrAbdulRazak_MD @rehman_naveed @adrisdoc @AAPneonatal @EBNEO @souvik_neo @NeoTECaN @neosatyan @waseemoddin @NielsRochow Researchers asked this question in adults a half century after epi use became part of routine practice and subjected it to rigorous scrutiny https://t.co/UT8K559p0u
https://t.co/cxMrcuEOb8
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. N Engl J Med. 2018 Aug 23;379(8):711-721. doi: 10.1056/NEJMoa1806842. Epub 2018 Jul 18. PMID: 30021076.
RT @TheSGEM: PICO from this RCT on epinephrine for OHCA. https://t.co/CoC7cb1HbG @NEJM @JWatch https://t.co/IIac5wAFQ8
PICO from this RCT on epinephrine for OHCA. https://t.co/CoC7cb1HbG @NEJM @JWatch https://t.co/IIac5wAFQ8
RT @realscientists: The PARAMEDIC2 trial compared epinephrine (adrenaline) to placebo in OHCA. Epi got more pulses back (ROSC), but those…
The PARAMEDIC2 trial compared epinephrine (adrenaline) to placebo in OHCA. Epi got more pulses back (ROSC), but those that survived had worse neurological outcomes at hospital discharge. Trial had overall low survival rate, making generalizability tough. https://t.co/cJwNnSNCZK https://t.co/HfkLu3btQx
RT @EmilyIngridST: @wendyburn Not anaphylaxis but related and interesting in case you missed it (can’t read everything!) https://t.co/9wpuZ…
@wendyburn Not anaphylaxis but related and interesting in case you missed it (can’t read everything!) https://t.co/9wpuZLBRnD and the Resus Room discussion at the time https://t.co/J0uzxJAmR1
@MarkGeyerMD @VPrasadMDMPH @Luke1732Mullen Adrenaline in cardiac arrest was always accepted as SoC. The UK were brave enough to run a trial... https://t.co/5OxsGI62Ai No big pharma...
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest | NEJM https://t.co/EHzqVXznAv
@sargsyanz we could fix the problem if we stop giving Epi in cardiac arrest!
院外心停止を対象としたエピネフリンのランダム化比較試験 https://t.co/cxMrcuEOb8
RT @littlepixie3: @C7RKY They were testing to see if adrenaline had an effect on arrest patients in the community. Paramedics were sent out…
RT @CHESTCritCare: Epi is also the first ACLS drug, and has been considered "standard of care" for decades now, several studies have associ…
RT @CHESTCritCare: Epi is also the first ACLS drug, and has been considered "standard of care" for decades now, several studies have associ…
Epi is also the first ACLS drug, and has been considered "standard of care" for decades now, several studies have associated it with increased rate of ROSC, but more recent evidence not showing better survival. https://t.co/i4Fy3xz1nc
@Eska80 @EChabriere https://t.co/kPJDCcQSjn
RT @HansvanSchuppen: #Adrenaline in #resuscitation for cardiac arrest: better for survival but worse for the brain so no increase in good s…
RT @accpemedprn: Let's kick off our fave pre-hospital trials for this #EMSWeek2020: First up is #PARAMEDIC2! Well designed and executed to…
RT @accpemedprn: Let's kick off our fave pre-hospital trials for this #EMSWeek2020: First up is #PARAMEDIC2! Well designed and executed to…
Let's kick off our fave pre-hospital trials for this #EMSWeek2020: First up is #PARAMEDIC2! Well designed and executed to answer a challenging question - does epi improve outcomes in #OHCA? Still generating discussion 2 years later https://t.co/Dh9Cp8UliK
RT @krychtiukmd: Epinephrine in out of hospital cardiac arrest - higher 30-day survival, BUT no diff in favorable neurologic outcome! now?…
RT @shanfernands: @dwmessenger @TheSGEM Hard to think of too many papers that have on their own changed worldwide EM practice more than the…
@dwmessenger @TheSGEM Hard to think of too many papers that have on their own changed worldwide EM practice more than the REVERT trial: https://t.co/R4GGl6lR5T For most controversial, would also add PARAMEDIC-2, which has challenged dogma on OHCA managmeent: https://t.co/PAiUAkvV7p
@idrissaberkane non. les essais cliniques contrôlés sont l'unique source de savoir fiable en médecine. c bien ce qui est reproche au Pr Raoult, pas le double aveugle. on peut tout tester avec un groupe contrôle même l'adrénaline vs placebo dans l'arrêt cardiaque https://t.co/JdTUHWnZiL
@JBRPHND @MedicusFR Nuremberg, Helsinki, des conférences de vendeurs de crème contre l'acné quoi... tenez juste une étude clinique menée selon les règles de l'art : 8000 patients adrenaline vs placebo dans l'arrêt cardiaque. comme quoi on peut faire de la bonne médecine https://t.co/JdTUHWnZiL
@ChristopheDigel @Denis_Faust @fluidloading https://t.co/4C3hbGB3mE
RT @PontealdiaURG: #RevisiónUrgencias La #adrenalina en PCR extrahospitalaria mejoró la supervivencia al mes pero sin resultado neurológico…
RT @intensivecare_c: 院外心停止に対して、エピネフリン vs プラセボを比較したPARAMEDIC2はこちら。 https://t.co/0lFlouqrci
RT @intensivecare_c: 院外心停止に対して、エピネフリン vs プラセボを比較したPARAMEDIC2はこちら。 https://t.co/0lFlouqrci
RT @intensivecare_c: 院外心停止に対して、エピネフリン vs プラセボを比較したPARAMEDIC2はこちら。 https://t.co/0lFlouqrci
RT @intensivecare_c: 院外心停止に対して、エピネフリン vs プラセボを比較したPARAMEDIC2はこちら。 https://t.co/0lFlouqrci
院外心停止に対して、エピネフリン vs プラセボを比較したPARAMEDIC2はこちら。 https://t.co/0lFlouqrci
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/ceVRujCdde
RT @FsmAcil: Hands-only CPR is going to be the future of resuscitation, I guess
RT @seth_kelly: @amalmattu Perkins et al. "A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest" DOI: 10.1056/NEJMoa1806842.…
RT @seth_kelly: @amalmattu Perkins et al. "A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest" DOI: 10.1056/NEJMoa1806842.…
@amalmattu Perkins et al. "A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest" DOI: 10.1056/NEJMoa1806842. EPI = early survival, worse neuro; appears best in non-shock rhythms; less effective when given late. #resus2019
RT @NEJM: Original Article: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest (PARAMEDIC2) https://t.co/r9uHhc4GC0 Edito…
@NealSParikhMD @barttels2 @reverendofdoubt @TheSGEM @ohsuneuro @JAMANeuro @NeurologyToday @TheLancetNeuro @NeurologyCP @theABN_Info @kevinmd @AmbuUSA @AANMember As an example, here is (re)analysis of paramedic2 trial, where instead of combining/binning death(6) with score of 5, ordinal analysis was done with 5 ranked worse than 6. https://t.co/AJLAGISDBD
RT @MCQALS: Regarding Epinephrine (adrenaline), which of the following statements is CORRECT?: Check your answers at: https://t.co/GYyzy5DW…
Regarding Epinephrine (adrenaline), which of the following statements is CORRECT?: Check your answers at: https://t.co/GYyzy5DWAT https://t.co/3i75iXbBng https://t.co/KlGC91svEm
6/10 must know papers from 2018 ... @SaudiEmergency #sasem19 A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. - PubMed - NCBI https://t.co/zH4UmttsgS
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. Significantly higher rate of 30-day survival, no improved neurological outcome. #paramedic #OHCA https://t.co/5JvWKssHdh
Discusión: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/0NRAh3O90B Cartas al Editor: Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/lNckDWJWwG Antecedentes: https://t.co/nihm6H77nf
#CCR19 Trial: Paramedic2 Speaker / Author: Gavin Perkins What was the question: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest https://t.co/C54wRsl2rW https://t.co/9KYHJTtyaZ
RT @ICS_updates: PARAMEDIC-2: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - Gavin Perkins https://t.co/MB2YeORR7g…
RT @ICS_updates: PARAMEDIC-2: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - Gavin Perkins https://t.co/MB2YeORR7g…
RT @ICS_updates: PARAMEDIC-2: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - Gavin Perkins https://t.co/MB2YeORR7g…
RT @ICS_updates: PARAMEDIC-2: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - Gavin Perkins https://t.co/MB2YeORR7g…
PARAMEDIC-2: A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest - Gavin Perkins https://t.co/MB2YeORR7g https://t.co/GoDthQlfym
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. - PubMed - NCBI https://t.co/1tQi5Oa5bb
Open access! The PARAMEDIC-2 trial: a randomised placebo-controlled trial of adrenaline (epinephrine) in OOH cardiac arrest #FOAMed https://www.nejm.org/doi/full/10.1056/NEJMoa1806842